Loading...
 

Volume 29, Issue 3, September 2018

Sign in to download the Issue in PDF format.

Mediterr J Rheumatol 2018;29(3):148-55
Diffuse connective tissue disorders in HIV-infected patients
Authors Information

1. Department of Haematology, University General Hospital of Alexandroupolis, Thrace, Greece
2. Outpatient Department of Rheumatology, University General Hospital of Alexandroupolis, Thrace, Greece

Abstract

Background: Human immunodeficiency virus (HIV) infection has been associated with various autoimmune disorders. Aim: To review the spectrum of diffuse connective tissue disorders (dCTD) in HIV-infected patients, in the context of highly active anti-retroviral therapy. Methods: Electronic search of the literature was performed using the terms HIV, AIDS, autoimmune, rheumatic/rheumatological, immune reconstitution inflammatory syndrome, Systemic Lupus Erythematosus, Diffuse Infiltrative Lymphocytosis Syndrome, Sjogren’s syndrome, vasculitis, Behçet's disease, cryoglobulins, Henoch-Schönlein purpura, and antiphospholipid syndrome. Results: We reviewed the clinical manifestations, natural history and treatment of dCTDs, since the implementation of Highly Active Anti-Retroviral Therapy (HAART), and the emergence of new pathogenic mechanisms, such as the immune reconstitution inflammatory syndrome. Conclusions: Caution in differentiating clinical and laboratory findings of dCTDs from non-specific manifestations of acute and chronic HIV infection is warranted due to the common presentation. Patients with chronic infection and access to HAART have a normal life expectancy and dCTDs, although rare, must be correctly addressed.  HAART alone or combined with immunosuppressive therapy result in favourable outcomes.